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Abstract: Current Escherichia coli antibiofilm treatments comprise a combination of antibiotics 
commonly used against planktonic cells, leading to treatment failure. A better understanding of the 
genes involved in biofilm formation could facilitate the development of efficient and specific new 
antibiofilm treatments. A total of 2578 E. coli mutants were generated by transposon insertion, of 
which 536 were analysed in this study. After sequencing, Tn263 mutant, classified as low biofilm-
former (LF) compared to the wild-type (wt) strain (ATCC 25922), showed an interruption in the 
purL gene, involved in the de novo purine biosynthesis pathway. To elucidate the role of purL in 
biofilm formation, a knockout was generated showing reduced production of curli fibres, leading 
to an impaired biofilm formation. These conditions were restored by complementation of the strain 
or addition of exogenous inosine. Proteomic and transcriptional analyses were performed to 
characterise the differences caused by purL alterations. Thirteen proteins were altered compared to 
wt. The corresponding genes were analysed by qRT-PCR not only in the Tn263 and wt, but also in 
clinical strains with different biofilm activity. Overall, this study suggests that purL is essential for 
biofilm formation in E. coli and can be considered as a potential antibiofilm target.  
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1. Introduction 
Escherichia coli is a well-characterised microorganism frequently used as a laboratory model and 
in industrial microbiology [1]. In the human body, most gut-resident E. coli prevent colonisation by 
pathogenic bacteria and favour the host by producing vitamin K and B12, which are essential during 
the blood coagulation process and the formation of red blood cells, respectively [2–4]. However, some 
E. coli can also cause intestinal or extraintestinal infections such as urinary tract infections (UTIs), 
meningitis, and neonatal sepsis [5–9]. E. coli grows as free-living cells or biofilm-forming 
communities. Microbial biofilms are well-organized communities where microorganisms live 
embedded in a self-produced extracellular polymeric substance (EPS) which protects against adverse 
environmental conditions [6]. Biofilms are ubiquitous, being found attached to biological or inert 
surfaces in diverse ecological niches. In addition, E. coli biofilms cause several medical device-related 
infections, including joint infections, intravascular catheter infections, and catheter-associated 
urinary tract infections (CAUTI) [6,10,11]. Unfortunately, biofilm-forming organisms have an 
increased tolerance to antibiotics due to the reduced penetration of the antibiotic through the biofilm 
extracellular matrix (ECM) [12,13]. Likewise, the bacteria within the biofilms evade the immune 
system through various defence mechanisms, such as by avoiding the complement system and 
phagocytosis or by acting as a physical barrier [12]. Therefore, there is an unmet need to elucidate 
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Abstract: Current Escherichia coli antibiofilm treatments comprise a combination of antibiotics
commonly used against planktonic cells, leading to treatment failure. A better understanding of the
genes involved in biofilm formation could facilitate the development of efficient and specific new
antibiofilm treatments. A total of 2578 E. coli mutants were generated by transposon insertion, of which
536 were analysed in this study. After sequencing, Tn263 mutant, classified as low biofilm-former
(LF) compared to the wild-type (wt) strain (ATCC 25922), showed an interruption in the purL gene,
involved in the de novo purine biosynthesis pathway. To elucidate the role of purL in biofilm formation,
a knockout was generated showing reduced production of curli fibres, leading to an impaired biofilm
formation. These conditions were restored by complementation of the strain or addition of exogenous
inosine. Proteomic and transcriptional analyses were performed to characterise the differences caused
by purL alterations. Thirteen proteins were altered compared to wt. The corresponding genes were
analysed by qRT-PCR not only in the Tn263 and wt, but also in clinical strains with different biofilm
activity. Overall, this study suggests that purL is essential for biofilm formation in E. coli and can be
considered as a potential antibiofilm target.
Keywords: biofilm; E. coli; purL; transposon insertion; curli fibers
1. Introduction
Escherichia coli is a well-characterised microorganism frequently used as a laboratory model and
in industrial microbiology [1]. In the human body, most gut-resident E. coli prevent colonisation by
pathogenic bacteria and favour the host by producing vitamin K and B12, which are essential during the
blood coagulation process and the formation of red blood cells, respectively [2–4]. However, some E. coli
can also cause intestinal or extraintestinal infections such as urinary tract infections (UTIs), meningitis,
and neonatal sepsis [5–9]. E. coli grows as free-living cells or biofilm-forming communities. Microbial
biofilms are well-organized communities where microorganisms live embedded in a self-produced
extracellular polymeric substance (EPS) which protects against adverse environmental conditions [6].
Biofilms are ubiquitous, being found attached to biological or inert surfaces in diverse ecological niches.
In addition, E. coli biofilms cause several medical device-related infections, including joint infections,
intravascular catheter infections, and catheter-associated urinary tract infections (CAUTI) [6,10,11].
Unfortunately, biofilm-forming organisms have an increased tolerance to antibiotics due to the
reduced penetration of the antibiotic through the biofilm extracellular matrix (ECM) [12,13]. Likewise,
the bacteria within the biofilms evade the immune system through various defence mechanisms,
such as by avoiding the complement system and phagocytosis or by acting as a physical barrier [12].
Therefore, there is an unmet need to elucidate new ways to treat biofilm-related infections. In this
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sense, to understand the molecular mechanisms underlying biofilm formation, it is essential to
develop efficient new clinical treatments. Several studies have described the mechanisms and gene
regulation involved during the three general phases of biofilm formation: attachment, development,
and dispersal [8,14–17]. For example, some of the well-characterised virulence factor genes among
E. coli strains during the initial stages include type 1 fimbriae or pili, curli fimbriae, and flagella.
Specifically, disruption in fim genes (fimA and fimH, that encode type-1 fimbrial protein A chain and
type 1 fimbrin D-mannose specific adhesion, respectively) reduces initial attachment to abiotic surfaces
and biofilm production [18]. Curli fimbriae, encoded by the csgBAC operon, provide initial adhesion
to abiotic surfaces and promote cell aggregation [19]. Thus, alteration of the csgA gene triggers
reduced biofilm formation due to a decreased production of the main curli protein CsgA subunit [20].
In addition, alterations in genes involved in motility (fli, flh, mot, and che alleles) also decrease biofilm
formation [5]. On the other hand, the quorum sensing (QS) system plays a critical role in microbial
biofilms during development and dispersal stages.
Despite the current knowledge about these genes, the investigation of new essential genes/proteins
during biofilm formation could elucidate unknown candidate genes with a higher potential as
antibiofilm targets. In the present study we focus on protein expression and the comparison of gene
transcription between an E. coli wt strain and the isogenic defective biofilm mutants (Tn) produced
by transposon insertion. Taking this into account, the aim of this work was to identify new genes
involved in biofilm formation in E. coli using phenotypic and molecular tools.
2. Materials and Methods
2.1. Culture of E. coli and Electrocompetent Cells
The E. coli ATCC 25922 reference strain, used as the wt strain in this study, was grown for 24 h at
37 ◦C in Luria Bertani (LB) agar (Miller’s LB AGAR, Condalab, Madrid, Spain). Electrocompetent cells
were made after the overnight culture of a single colony in LB broth (Miller’s LB Broth, Condalab) at
37 ◦C with shaking at 180 rpm. One millilitre of the overnight culture was used to inoculate 100 mL
prewarmed (37 ◦C) LB broth and incubated in aerobic conditions at 37 ◦C under shaking at 180 rpm.
When bacteria reached the mid-log phase (optical density (OD) at 600 nm = 0.6 ± 0.2), the cells were
incubated on ice for 20 min. Bacterial cells were pelleted at 7000× g for 10 min, and washed three
times: first with 50 mL of ice-cold water, second with 25 mL of ice-cold water, and lastly with 2.5 mL of
ice-cold 10% glycerol. Electrocompetent cells were aliquoted and stored at −80 ◦C.
2.2. Transposon Mutagenesis
Transposon mutagenesis was carried out according to the manufacturer’s recommendations
(Lucigen). Briefly, 1 µL of EZ-Tn5™ <R6Kγori/KAN-2> Tnp Transposome™ kit (Epicentre Lucigen,
bioNova Científica S.L., Madrid, Spain) was mixed with 45 µL of E. coli wt electrocompetent cells and
included in a 0.2 cm electro-cuvette (Bio-Rad, Madrid, Spain). The cells were electroporated using the
Pre-Set protocol from the Gene Pulser Xcell™ Electroporation Systems (Bio-Rad) at 25 µF, 200 Ohms,
2500 V. The electroporated cells were recovered immediately in 1 mL of Super Optimal broth with
Catabolite repression (S.O.C.) medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl,
10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose) and incubated at 37 ◦C with shaking (100 rpm) for
60 min. The incubated product was diluted 1:10, and 50 µL aliquots were plated onto LB agar with
kanamycin-50 µg/mL. Each colony grown was stored separately at −80 ◦C in BD Difco™ Skim Milk
(Becton Dickinson, Madrid, Spain) for further analysis. The efficiency of the electrocompetent cells
was >107 colony forming units (CFU)/µg of DNA.
2.3. Biofilm Analysis
Five hundred and thirty-six of a total of 2578 transposon mutants were characterised in terms
of biofilm production using a protocol previously standardised in our research group [21]. Briefly,
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all isolates were cultured overnight in LB agar at 37 ◦C in aerobic conditions. The cultures were
established by the direct colony suspension method at 37 ◦C with shaking (180 rpm) in LB broth
and then grown overnight. After incubation, colonies were diluted 1:100 in 200 µL of M63 medium
(13.5 g/L KH2PO4, 2 g/L (NH4)2SO4, 5.0 × 10−4 g/L FeSO4, 1 mL 1 M MgSO4·7H2O), supplemented
with 0.25% glucose and adjusted to pH 7 (with KOH) and tested in 96-well flat-bottomed non-treated
polystyrene microtiter plates with lids (Nunc™ Edge 2.0, VWR International, Barcelona, Spain) at
30 ◦C for 48 h. After incubation, biofilm was quantified using a crystal violet technique previously
described by our group [21]. In brief, liquid culture from M63 medium was carefully removed, and the
biofilm mass was washed twice with 210 µL of 1× phosphate-buffered saline (PBS) (pH 7.2) and dried
at 65 ◦C for at least 20 min. Biofilms were stained with 200 µL of 2% (v/v) solution of crystal violet
(CV) and incubated for 10 min at room temperature. Afterwards, the CV was completely removed,
washed twice with 1× PBS and heat-fixed at 65 ◦C for 60 min. The CV was eluted by adding 200 µL of
33% acetic acid. Biofilm formation was measured at 580 nm using a Microplate Spectrophotometer
(EPOCH 2 microplate reader, BioTek, Winooski, VT, USA).
The biofilm production of each sample was tested in triplicate, and samples showing an absorbance
less than or equal to the positive control (ATCC 25922) were retested. Finally, the mutants were
classified into three groups using the paired Student’s t-test (adjusted p < 0.05, considered significant
and listed in Supplementary Table S1) comparing the normalised absorbance of each mutant (A Tn)
with the absorbance of the reference strain (A ATCC). Only statistically different strains were considered
to be LF or high biofilm formers (HF), whereas no statistically significant differences were considered
as biofilm formers (F).
2.4. Phenotypic Characterization of Mutants
2.4.1. Growth Curves
To detect deficiencies in bacterial growth, the fitness of the selected mutants was tested. A single
colony of each strain was grown overnight in LB broth at 37 ◦C with shaking at 180 rpm. After incubation,
cultures were centrifuged and adjusted at OD600nm = 1 with fresh LB, followed by dilution of 1:100
and plated onto 96-well flat-bottomed polystyrene microtiter plates with lids (Nunc™ Edge 2.0, VWR
International, Barcelona, Spain). The plates were incubated at 37 ◦C with double orbital shaking
(180 rpm). The absorbance was measured every 15 min for 24 h using the Epoch 2 Microplate
Spectrophotometer. Each sample was repeated four times. LB without inoculum was used as a negative
control. A plot of the natural log (Ln) of Absorbance versus time during the exponential phase yielded
a straight line and the slope of this was equal to the specific growth rate (µ). The µ obtained for each
strain was statistically compared to the µ of the wt strain.
Bacterial growth in M63 broth was measured by colony counting instead of Epoch 2, as the low
growth of the mutant strain and the colourless medium limits its detection by spectrophotometer.
Bacterial viability was also measured using the LIVE/DEAD® BacLight Bacterial Viability Kit, which uses
mixtures of SYTO® 9 green-fluorescent nucleic acid stain and the red-fluorescent nucleic acid stain,
propidium iodide (PI). According to the manufacturer, when both dyes are present, it is possible to
distinguish between intact and damaged bacterial cells. PI penetrates only into bacteria with damaged
membranes, causing a reduction in the SYTO® 9 stain. Thus, bacteria with intact cell membranes
stain fluorescent green, whereas bacteria with damaged membranes stain fluorescent red. Therefore,
after incubation, biofilms were washed twice with 1× PBS (pH 7.2), cells were detached with a scraper,
transferred into an Eppendorf tube, and sonicated at 37 kHz for 2 min using an ultrasonic bath (Fisher
Scientific FB 15053, Waltham, MA, USA) following by vigorous vortexing for 1 min. The cells were then
stained following the kit protocol and observed in the Olympus IX51 inverted fluorescence microscope.
Three biological and technical replicates were done and three fields of each well were observed and
imaged using the Fiji ImageJ software. Integrated density (staining intensity), defined as the sum of the
values of the pixels in the image selected was measured and the percentage of viability was calculated.
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2.4.2. Swimming Assay
A motility assay was performed as previously described [9]. Briefly, transposon mutant bacteria
were incubated onto LB-kanamycin plates for 24 h at 37 ◦C. After incubation, a single colony was
streaked in a 0.3% LB agar tube with 0.001% 2,3,5-triphenyl tetrazolium chloride (TTC). The tubes
were incubated for 20 h at 37 ◦C. All completely red-stained tubes were considered positive. A motility
assay was performed in triplicate for each strain.
2.4.3. Congo Red Assay
Curli production was determined using the Congo Red (CR) assay as previously described by
Prigent-Combaret et al. [20]. YESCA-CR agar plates were made with yeast extract and casamino
acid agar (YESCA: 1 g L−1 yeast extract, 10 g L−1 casamino acids, 20 g L−1 agar), and autoclaved at
121 ◦C. After sterilisation, filter-sterilised CR and Brilliant Blue G (100 µg mL−1 and 10 µg mL−1 final
concentrations, respectively) were added. Transposon mutants were streaked in LB broth and grown
at 37 ◦C overnight. Five microliters of overnight culture were spotted on the centre of the CR agar
plate and incubated at 28 ◦C for 48 h. Dark red colonies were indicative of adhesion fibers while white
or light pink colonies were indicative that fibers were not produced.
2.4.4. Hemagglutination Assays
Type 1 fimbriae (pili) can be tested by hemagglutination assays. The fimH gene encoded the
mannose-specific adhesin, located at the end of the pilus, resulting in hemagglutination in the presence
of mannose. Therefore, the presence of hemagglutination in the samples indicated the expression of
FimH adhesin. The assay was performed according to the protocol described by Hultgren et al. [22].
Bacterial cells were grown overnight in LB agar. After incubation, each strain was suspended in
1× PBS to obtain an OD600nm of 1.0. One mL of the suspension was centrifuged, and the pellet was
resuspended in 0.1 mL of 1× PBS. Twenty-five µL (1 × 109 to 2 × 109 bacteria) were serially diluted
in 96-well round-bottomed polystyrene microtiter plates containing 25 µL of 1× PBS in each well.
An equal volume of 2.5% previously washed sheep erythrocytes was added and, after mixing, the plates
were incubated at 4 ◦C for 4 to 18 h. The endpoint was defined as the highest dilution at which
erythrocyte buttons were not observed. The titre was expressed as the reciprocal of the endpoint and
then expressed in Log2.
2.5. Genotypic Characterization of Mutants
2.5.1. DNA Sequencing
Two mutants with the most significant loss of ability to form biofilm were selected for DNA
sequencing. Each strain was cultured onto LB agar plates at 37 ◦C in aerobic conditions for 24 h.
One colony was inoculated in 5 mL of LB broth and placed on ice when the OD reached mid-log phase.
DNA extraction was performed using the Bacterial Genomic DNA Isolation Kit (Norgen Biotek Corp,
Schmon Pkwy, Thorold, ON, Canada) following the manufacturer’s recommendations. Then, DNA
was quantified using a Qubit 4 Fluorometer (Thermo Scientific, Waltham, MA, USA).
The genomic DNA material was used for the preparation of TrueSeq Illumina libraries (Illumina
Inc, San Diego, CA, USA). The Illumina HiSeq2500 system was used as a sequencing platform
with a 2× 125 bp paired-end strategy to generate 6,000,000 reads. The libraries were checked for
quality analysis using FASTQC available at (http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/)
implemented by the GPRO suit (https://gpro.biotechvana.com/).
The FASTQ files were pre-processed using Cutadapt software to remove primer adapters [23]
and the sequencing quality was established with Prinseq with which reads with less than 50 bp
and a concentration of up to 15% of Ns were discarded [24]. Then, de novo genome assemblies
were conducted with the SPAdes Genome Assembler [25]. Reads were mapped onto the reference
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genome (Escherichia coli: GenBank: CP009072.1) using Bwa software [26]. The transposon was detected
comparing the reconstructed genome to wt strain using the Mauve software [27].
2.5.2. purL Gene Disruption
To confirm the role of purL in biofilm formation, the disruption of this gene was done using the λ
red recombination system according to the protocol described by Datsenko and Wanner [28]. Briefly,
the E. coli wt electrocompetent cells were electroporated with 50 ng of a red recombinase expression
plasmid (pKD46). Transformants were grown in LB broth with ampicillin 100 µg/mL (Sigma-Aldrich,
Milwaukee, WI, USA), and L-arabinose 10 mM (TCI Europe, Zwijndrecht, Belgium), at 30 ◦C to an
OD600 of 0.6 ± 0.2 and then were remade as electrocompetent cells.
The deletion of purL was obtained by PCR. To generate the PCR fragments, the primers were
designed by priming, upstream and downstream, the sites flanking the chloramphenicol resistance
gene in pKD3 and with ends homologous to upstream and downstream chromosomal sequences
for targeting the purL gene. N-terminal deletion primer had a 50-nt 5’extension including the
gene initiation codon and the 21-nt sequence 5’-GTGTAGGCTGGAGCTGCTTCG-3’. C-terminal
deletion primers consisted of 21 nt for the C-terminal region including the termination codon, 29-nt




PCR products were gel-purified with the E.Z.N.A. ® Gel Extraction Kit (Omega Bio-tek, Norcross,
GA, USA) and digested with DpnI (Thermo Scientific™, Waltham, MA, USA). 500 ng of the re-purified
product were mixed with 100 µL of electrocompetent cells carrying the pKD46 and electroporated.
The cells were immediately added to 1 mL S.O.C. medium, incubated at 37 ◦C with shaking (180 rpm)
for 2 h, centrifuged, and resuspended in 500 µL of fresh S.O.C. medium. Then, 250 µL were spread onto
each LB agar plate containing chloramphenicol (Cm) 10 µg/mL to select Cm-resistant transformants.
Afterwards, the obtained transformants were incubated at 43 ◦C in LB agar without antibiotics and
tested for ampicillin sensitivity to test for loss of the pKD46 helper plasmid. Each colony was stored
separately at −80 ◦C in BD Difco™ Skim Milk (Becton Dickinson, Madrid, Spain) for further analysis.
Different PCRs were performed to demonstrate the successful disruption of the purL gene. The primers
used are listed in Supplementary Table S2.
The growth curve, biofilm formation, and curli fibers formation of the ∆purL::cat knockout were
also evaluated as previously described.
2.5.3. purL Gene Complementation
The knockout strain was complemented to recover biofilm formation capacity. Briefly, purified
PCR product of the purL gene was ligated to pGEM®-T vector System (Promega, Madison, WI, USA)
using the T4 DNA Ligase and cloned into the competent knockout strain. The complemented bacteria
were selected in LB agar plates containing ampicillin 100 µg/mL. Each colony was stored separately
at −80 ◦C in Skim Milk for further analysis. Successful complementation was confirmed by PCR
using the T7 promoter primer and an internal primer of the purL gene (Supplementary Table S2).
Then, the biofilm formation, growth curves, and curli production tests of the complemented bacteria
were assessed.
2.5.4. Effect of Inosine Addition to the Biofilm Formation Ability of the purL Mutant.
To examine the recovery of the ability to form biofilm of the purL mutant by the addition of
an exogenous source of purine, M63 broth supplemented with double decreasing concentrations of
inosine ranging between 50 and 1.56 µg/mL was used for biofilm formation analysis and growth curves,
following the protocols previously described. Curli production was also measured by supplementing
YESCA-CR agar with inosine 50 µg/mL.
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2.6. Proteomic Characterization of Mutants
2.6.1. Protein Isolation
The protein isolation of the wt strain, as well as the proteomic isolation of the Tn263, the E. coli
mutant selected for proteomic and transcriptional analysis, was performed as follows: the strains
were cultured inoculating a single colony into LB broth for 18 h at 37 ◦C with shaking at 180 rpm to
reach a cell concentration of 1 × 109 CFU/mL. Colonies were diluted 1:100 in 70 mL of M63 medium
supplemented with 0.25% glucose in a T75 non-treated flask (Thermo Scientific™Nunc™, Waltham,
MA, USA) and incubated at 30 ◦C for 72 h without shaking. The medium was carefully replaced
by a fresh medium every 24 h. Subsequently, the medium was aspirated to remove planktonic cells,
and flasks were washed twice with 20 mL of 1× PBS (pH 7.2) to remove unattached or loosely attached
cells. Cells were then resuspended with 25 mL of 10 mM Tris-KCl (pH 7.8, 150 mM KCl) and sonicated
at 37 kHz for 4 min using an ultrasonic bath (Fisher Scientific FB 15053, Waltham, MA, USA). Cells
were harvested in 50 mL sterile falcon tubes (Deltalab, Rubí, Spain) and spun down at 3500× g for
10 min at 4 ◦C. The cell pellet was washed 3 times in 50mL of Tris-KCl and finally transferred into
an Eppendorf tube and pelleted at 12,000× g for 10 min at 4 ◦C. The pellet was homogenized in lysis
buffer (7M urea, 2M thiourea, 4% CHAPS, 2% ASB-14), and supplemented with protease inhibitor
(GE Healthcare, Chicago, IL, USA). Bacterial cells were broken by sonication for 10 min with a cycle of
20 s on/59 s off at 4 ◦C on ice-water. After cell disruption, the samples were centrifuged at 3500× g for
15 min at 4 ◦C, and the supernatant was aliquoted and stored at −80 ◦C. The protein extracts were
quantified using the 2-D Quant Kit and purified with the 2-D Clean-Up Kit (GE Healthcare). Fifty µg of
protein was added to 0.5% of immobilized pH gradient buffer 4–7 and 20 mM of dithiothreitol (DTT).
Each sample was assessed in three biological replicates.
2.6.2. Two-Dimensional SDS-PAGE Analysis
Two-dimensional sodium dodecyl sulfate polyacrylamide gel (2D SDS-PAGE) was performed as
previously described [29]. Briefly, the Immobiline DryStrip Gels (IPG strips) (GE Healthcare) were
hydrated following the manufacturer’s recommendations for 18 h at room temperature. The protein
sample was loaded onto an IPG strip for first dimension separation by isoelectric focusing using
24 cm pH 4–7 linear IPG strips for 20 h (200 V for 2 h, 500 V for 3 h, 1000 V for 4 h, and 8000 V
for 11 h, 20 ◦C) in an IPGphor I (GE Healthcare). After focusing, each strip was equilibrated in
10 mL of equilibration buffer (6M Urea, 75 mM Tris-HCl pH 8.8, 29.3% glycerol, 2% SDS and 0.002%
bromophenol blue supplemented with DTT or iodoacetamide and 1% DTT) for 15 min and acetylated
with iodoacetamide, and subsequently placed onto 12.5% polyacrylamide gels (24 cm× 20 cm) prepared
as described by Laemmli [30]. The second dimension was performed using an EttanTM DALT six
system (GE Healthcare). Gels were run at 20 ◦C using 80 V, 10 mA/strip, and 1 W/strip for 1 h, followed
by 500 V, 40 mA/strip and13 W/strip until the bromophenol blue tracking front had run off the end of
the gel.
2.6.3. Gel Staining and Protein Detection
Two-dimensional gels were silver stained as described previously [31]. Briefly, the gels were fixed
for 18 h in 40% ethanol and 10% acetic acid, followed by incubation in sensitizing solution for 1 h in
30% ethanol with 0.02% (w/v) sodium thiosulfate. The gels were washed three times in distilled water
for 5 min and treated with 0.1% (w/v) silver nitrate for 30 min. The gels were washed again twice with
distilled water for 1 min. The developing step was performed with 3% (w/v) sodium carbonate and
0.025% (v/v) formaldehyde until the desired contrast was reached. Developing reaction was stopped
with 1.5% (w/v) EDTA (Ethylenediaminetetraacetic acid)-Na2 for 45 min. Finally, the gels were washed
twice with distilled water.
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2.6.4. Mass-Spectrometry Analysis for Orbitrap
Selected protein spots were excised from the gels digested with trypsin and analysed by liquid
chromatography coupled to mass spectrometry (Orbitrap Velos, Thermo, Waltham, MA, USA),
as described previously [32]. Proteins were identified through searching against E. coli proteins found
in the UniProt database, using Mascot (Matrix Science, London, UK) to search the SwissProt database
(2018_11, taxonomy restricted to E. coli proteins). Tandem mass spectrometry (MS/MS) spectra were
sought with a precursor mass tolerance of 10 ppm, fragment tolerance of 0.05 Da, trypsin specificity
with a maximum of two missed cleavages, cysteine carb-amido-methylation set as fixed modification,
and methionine oxidation as variable modification. The significance threshold for the identifications
was set at p < 0.05, with a minimum ions score of 20.
2.6.5. RNA Isolation and cDNA Synthesis
E. coli ATCC 25922, the transposon mutant strain Tn263, as well as three biofilm-forming and three
non-biofilm-forming clinical isolates were used for further gene expression analyses. Clinical strains
belonging to a collection of our research group were collected over six months between 2016 and 2017
from different hospitals in Barcelona, Spain). All strains had been previously identified by MALDI-TOF
mass spectrometry and their antimicrobial profile was tested according to the M100 guidelines (Clinical
& Laboratory Standards Institute, CLSI 2019) [33]. Origins of isolation and antibiotic resistance profiles
are shown in Supplementary Table S3. The strains were cultured by inoculating a single colony into
LB broth for 18 h at 37 ◦C with shaking at 180 rpm to reach a cell concentration of 1 × 109 CFU/mL.
Colonies were diluted 1:100 in 70 mL of M63 medium supplemented with 0.25% glucose in a T75 flask
for 72 h and 30 ◦C without shaking. Subsequently, the medium was aspirated to remove planktonic
cells, and flasks were washed twice with 20 mL of sterilized 1× PBS (pH 7.2). Cells were resuspended
in 3 mL of 1× PBS and treated with 6 mL of RNAprotect Bacteria Reagent (Qiagen, Hilden, Germany)
and vortexed and centrifuged at 5000 rpm for 20 min at room temperature. The supernatants were
discarded, and the pellets were treated with TE-lysozyme buffer (3 mg/mL in TE buffer pH 7.4).
Afterwards, RNA was extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s
recommendations. The total RNA was eluted in 50 µL of RNase-free water. RNA was isolated from
four independent samples.
The extracted RNA was treated with DNA-free™ Kit DNase Treatment and Removal Reagents
(Ambion, by Life Technologies AM1906, Waltham, MA, USA) to remove DNA contamination.
After DNase treatment, RNA was tested for residual genomic DNA contamination by polymerase
chain reaction (PCR) amplification of the adk gene and gel electrophoresis.
The total RNA concentration was quantified using NanoDrop 1000 (Thermo Scientific, Waltham,
MA, USA). An A260/280 ratio between 1.80 and 2.10 was considered optimal for RNA quality. cDNA
was synthesized using 500 ng of RNA in a reaction volume of 20 µL and the qScript cDNA SuperMix
reagent (Quanta Bioscience, 95048-100, Gaithersburg, MD, USA). The PCR amplification protocol
consists of one incubation step at 25 ◦C for 5 min, a DNA polymerization step at 42 ◦C for 30 min, and
a final enzyme deactivation step at 85 ◦C for 5 min. The final PCR product was diluted 1:10 and stored
at −20 ◦C. cDNA was used as a template for quantitative reverse transcription PCR (qRT–PCR) assays.
2.6.6. Gene Expression by qRT-PCR
qRT-PCR was carried out using 10µL of PowerUpTM SYBR Green Master Mix (Applied Biosystems,
Thermo Fisher Scientific, A25742, Foster City, CA, USA), 1 µL of primer mix (each reverse and forward
primers at a final concentration of 0.5 µM), 4µL of RNase-free water and 5µL of cDNA template.
Reactions were conducted in duplicate and the arcA gene was used as the reference gene for
normalisation of CT-values [34,35]. A non-template control reaction mixture was included for each gene.
Amplification was performed using StepOnePlusTM Real-Time PCR Systems (Applied Biosystems,
Foster City, CA, USA) being the cycling conditions: a pre-incubation step of 95 ◦C at 15 min, followed
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by an amplification step of 95 ◦C for 10 s, 60 ◦C for 30 s and 72 ◦C for 30 s repeated for 44 cycles,
and a melting curve analysis from 60 ◦C to 95 ◦C in 0.3 ◦C intervals. The relative fold-change of
mRNA transcripts in biofilms compared to mutant cultures was calculated using the 2−∆∆Ct method.
The primers used are listed in Supplementary Table S4. The primers designed in this study were made
using Primer Express Software v.3.0.1 (Applied Biosystems). Data analysis was based on at least three
independent experiments.
2.7. Data Plotting and Statistical Analysis
All statistical analyses were performed using GraphPad Prism v8.0.2 software (La Jolla, CA, USA)
unless otherwise stated. Graphs were created using GraphPad Prism v8.0.2 software and Tableau
Software (Seattle, WA, USA). Growth rates were evaluated via two-tailed Student t-test. One-way
ANOVA followed by post hoc Dunnett’s multiple comparison tests were used to analyse colony
counting in M63, LIVE/DEAD assay, and biofilm quantification after the addition of inosine. Statistical
quantification of relative protein levels was analysed with Progenesis SameSpots 4.6.206 (Totallab,
Newcastle, UK) and evaluated via ANOVA. The relative transcript levels of selected genes in wt strain,
Tn263 mutant and clinical isolates were calculated using the 2−∆∆Ct method. Two-tailed student t-test
was performed to compare wt vs Tn263 and biofilm-former vs non-biofilm former Differences were
considered statistically significant with a p value < 0.05.
3. Results
3.1. Mutant Selection by Biofilm Assays
A total of 2578 E. coli mutants by transposon insertion were generated, of which 536 were analysed
in this study. The mutants were further studied for their ability to form biofilm and compared to the
wt strain. Mutants presenting reduced biofilm-formation capacity (Table S1) were selected. A total of
116 mutants showed an altered biofilm formation rate in comparison with the wt strain. Among these,
20 were classified into the low biofilm formers (LF) group (3.73%) with an absorbance between 0.065
and 0.584, 420 mutants classified as formers (F) (78.36%) with an absorbance from 0.588 to 1.414 and
finally 96 were classified into the high biofilm formers (HF) (17.91%) with an absorbance higher than
1.414 (Figure 1). Into the low biofilm formers, Tn263 and Tn463 mutants showed the most significant
loss of biofilm formation with values of absorbance of 0.065 and 0.159, respectively.
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Figure 1. Scatter plot and marginal histograms of the ts. U per bars (green) indicate the number
of strains in the resp ctive percentage of biofilm formati . ight bars (blue) indicate the number of
stains in the respective absorbance values. Each spot represents a mutant where red colour indicates
low biofilm formation rates and blue corresponds to high biofilm formation rates. LF: low biofilm
former; F: biofilm former; HF: high biofilm former; A: absorbance.
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3.2. Phenotypic Characterization of Mutants
The 20 mutants classified into the low biofilm-forming capacity group (LF) were assessed with a
phenotypic comparative study.
3.2.1. Growth Curves in LB Broth
Transposon insertion can affect essential metabolic pathways and alter normal physiological
development. To detect these possible defects, growth curves were evaluated on 20 LF mutant strains
and compared to the wt strain (Figure 2). The analysis of the specific growth rate (µ) performed in
LB broth showed statistically significant differences in the Tn463 mutant in comparison to the wt
(p < 0.0001). The specific growth rates (µ) of the other mutant strains were similar to the wt, and no
statistically significant differences were found (p > 0.05). Figure 2 shows the entire growth curve
measuring absorbance every 15 min until 24 h of incubation.
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Figure 2. Fitness assay in Luria Bertani (LB) broth. Green represents the wild type curve; Red represents
Tn463. Grey represents the other 19 low biofilm-former (LF) transposon mutants, including Tn263.
Growth rates were statistically evaluated via two-tailed Student t-test.
3.2.2. Swimming, Congo Red and Hemagglutination Assays
In this section, 20 mutants were examined according to the phenotypic characterization of non-
biofilm-forming mutants. The results of the swimming, curli fibers production and hemagglutination
assays are summarized in Table 1.
In the swimming assay, no samples were found to be non-motile, indicating that defects in
biofilm formation are not related to defective flagella. Supplementary Figure S1 shows an example
of swimming classification using a defective mutant in the flhD gene as non-motile control and wt
as motile control. The ability to form curli fimbriae was evaluated using the CR assay in YESCA-CR
plates. In this assay, the Tn463 and Tn263 mutants showed significant differences caused by altered or
defective synthesis of curli. The results obtained in this assay are further discussed in Section 3.3.2.
Finally, all selected mutants showed positive hemagglutination, suggesting that type 1 pili are not
involved in the lack of biofilm formation in these mutants. Since Tn463 and Tn263 showed the the
most significant loss of biofilm formation and some changes in these assays, we analysed only these
mutants in the next section.
Pathogens 2020, 9, 774 10 of 22
Table 1. Phenotypical results of selected mutants.
Sample Swimming Curli Production Hemagglutination (Log2)
Tn5 + + 10
Tn29 + + 10
Tn42 + + 10
Tn82 + + 10
Tn90 + + 10
Tn119 + + 10
Tn143 + + 10
Tn 249 + + 10
Tn 251 + + 10
Tn 262 + + 10
Tn263 + - 10
Tn 337 + + 10
Tn 373 + + 10
Tn 406 + + 10
Tn 420 + + 10
Tn 425 + + 10
Tn 457 + + 10
Tn 463 + - 10
Tn 467 + + 10
Tn 474 + + 10
+: the mutant strain presents this characteristic; -: the mutant strain does not present this characteristic.
3.3. Genotypic Characterization of Mutants
3.3.1. DNA Sequencing
Since this study focused on low-forming strains after transposon insertion, the Tn263 and Tn463
mutants were selected for DNA sequencing. Although this was not within the scope of the present study,
the characterisation of the mutants with increased biofilm production could also lead to interesting
results and warrants further investigations.
According to the analysis of transposon insertion realised in collaboration with BIOTECHVANA
(Valencia, Spain), in the Tn463 mutant, the transposon was inserted in the csgA and cysB genes.
The csgBAC operon encodes the curli major subunit protein CsgA, the curli nucleator protein CsgB,
and the periplasmic chaperone CsgC [36]. The importance of curli fibers in biofilm formation has
previously been demonstrated as being linked to the synthesis of the exopolysaccharide cellulose,
a complementary factor of the biofilm matrix [37]. cysB gene encodes for CysB protein which is a
positive regulator of gene expression for the cysteine regulon, a system of ten or more loci involved in
the biosynthesis of L-cysteine from inorganic sulfate. Since csgA is a gene that has been previously
related to biofilm formation, we focused only on Tn263 for further analysis. In Tn263, the transposon
was only inserted in the purL gene. purL encodes for phosphoribosyl-formyl-glycinamidine synthase,
involved in the de novo purine biosynthesis pathway using 5-phospho-α-d-ribose 1-diphosphate
(PRPP) as a precursor for producing inosine monophosphate (IMP), which is the precursor of adenosine
monophosphate (AMP) and guanine monophosphate (GMP) (Figure 3). Interestingly, in our mutant,
the transposon insertion is located after 134 bp, position 45 in the protein affecting the N-terminal
domain and producing an unstable and non-functional protein but not affecting the gene expression.
Therefore, purine synthesis appears as an essential function whereby bacteria produce nucleotides
for the synthesis of DNA and RNA. Given the impact on the purine biosynthesis pathway, other
metabolism alterations in Tn263 were investigated using 2D SDS-PAGE analysis and subsequent
protein identification with orbitrap.
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3.3.2. Confirmation of the Role of the purL Gene in Biofilm Formation Using Its Knockout Strain
The ∆purL::cat (CmR), Tn263, and wt strains were cultivated in M63 broth. The mean value of
colony-forming units showed statistically significant differences in biofilm as well as planktonic culture
in both ∆purL::cat and the Tn263 mutant strains compared to the wt strain after 72 h of incubation
in M63 broth. In the same line, the measure of integrated density showed significant differences in
the total number of cells in biofilm (p = 0.0002 and p = 0.0008, Tn263 and purL mutant, respectively).
Nonetheless, the percentages of live and dead bacteria were highly similar between them (Table 2).
Table 2. Colony-forming units and Live/Dead BacLight Bacterial Viability assay.
Log10 CFU/ L ± SD Live/Dead
Biofilm Planktonic Integrated Density Live (% ± SD) Dead (% ± SD)
wild type 9.09 ± 0.24 8.99 ± 0.05 2.03 × 107 ± 4.86 × 106 85.40 ± 6.30 14.60 ± 6.30
Tn263 6.40 ± 0.51 6.96 ± 0.01 9.69 × 106 ± 2.79 × 106 86.32 ± 4.01 13.68 ± 4.01
∆purL::cat 6.22 ± 0.44 7.02 ± 0.02 1.11 × 107 ± 2.34 × 106 80.38 ± 6.88 19.62 ± 6.88
However, similar growth curves of the ∆purL::cat and the Tn263 mutant strains compared to the
wt strain were observed when the M63 culture media was supplemented with inosine (50 µg/mL).
The complemented strain ∆purL/purL+ showed similar growth curves to the wt strain in LB as well as
in M63. Supplementation with inosine did not have a significant effect on the growth curve of the
complemented strain. It should be noted that the general growth in the supplemented M63 broth
shows differences in the Log phase compared to the Log phase obtained with LB broth (Figure 4).
As already observed with the Tn263, the ∆purL::cat mutant was not able to form biofilm in M63
broth. However, when the medium was supplemented with inosine (50 µg/mL), both the ∆purL::cat
and the Tn263 mutants recovered the ability to form biofilm. Likewise, no statistically significant
differences after One-way ANOVAs followed by post hoc Dunnett’s multiple comparisons tests were
found using inosine concentrations ranging between 25 and 50 µg/mL for the ∆purL::cat and the
Tn263 mutants compared to the wt (p > 0.05). Nevertheless, inosine concentrations below 25 µg/mL
were insufficient to recover the ability to form a biofilm by the purL affected strains (Figure 5). Then,
after complementation with the purL gene using the pGEM®-T vector, the knockout strain also
recovered the ability to form biofilm, and the addition of inosine did not have a significant effect on its
biofilm formation. The complemented strain ∆purL/purL+ shows similar absorbance values than the
wt strain. The addition of inosine does not have a significant effect on its ability to form biofilm.
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Figure 5. Biofilm formation of ∆purL::cat mutant, Tn263, and the complemented strain ∆purL/purL+
using different concentrations of inosine. Each point in the curve represents mean values of A580nm
after 48 h of incubation; vertical bars correspond to standard deviations. The dashed line shows the
absorbance value of the wild type strain, used as control. The results were analysed by One-way
ANOVAs followed by post hoc Dunnett’s multiple comparisons tests.
Curli production was also measu ed by CR assay. ∆purL::cat and Tn263 mutants sho ed an
inability to bind CR and produced less curli fibers compared to the wt and the complemented strains.
Curli production was restored in the mutants by supplementing agar medium with inosine 50 µg/mL,
demonstrating the interplay between curli production, purine biosynthesis pathway, and biofilm
formation (Figure 6).
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Figure 6. Curli production. Dark red colony in yeast and casamino acid agar (YESCA-CR AGAR)
(ATCC and ∆purL/purL+) represents a curli producer, and light pink colonies (Tn263 and ∆purL::cat)
were associated with the defective phenotype. The defective phenotype of both mutants was restored
in the YESCA-CR + Inosine agar.
3.4. Proteomic Characterization of Mutant Tn 263
3.4.1. Comparative Proteomic Analyses of the wt and Tn263 by Two-Dimensional SDS-PAGE
To investigate the effect of transposon insertion at a molecular level, the Tn263 mutant was
compared to the wt strain using two-dimensional SDS-PAGE and mass spectrometry. Three biological
replicates of each sample were studied (Figure 7, Supplementary Figure S2, and Supplementary
Figure S3). Thirteen statistically significant spots were identified, 12 present in the wt strain, and one
in the mutant strain. Among he e, only spots with a score over 25 were considered for posterior
analyses (ANOVA p < 0.05) (Supplementary Table S5). The molecular weight (M ) and isoelectric
point (pI) of proteins were determined using MASCOT software and are in line with their theoretical
Mw/pI. The higher Mw might be the result of covalent binding, although lower Mw may be produced
by proteolysis or post-translational changes. Figure 7 provides a representative image of 2D-gels in
which spot differe ces are highlighted with arrows.
After mass-spectrometry identification and following pathway analysis, 13 proteins were classified
into three categories: metabolism and cell maintenance; genetic information processing and signalling
and cellular processes.
Within the metabolism regulation six proteins were included: CysJ, IlvC, ElbB, MgtA, Pta and
AdhE. CysJ is a nicotinamide adenine dinucleotide phosphate (NADPH) flavin oxidoreductase that
participates in the sulfite reductase complex (CysJ8I4). This protein is encoded by the cysJ gene,
which plays an essential role in sulphur metabolism, requir d for de novo biosynthesis of L-cysteine.
Aside from biosynthesis pathways, cysJ is also related to the detoxification system of toxic and
mutagenic N-hydroxylated nucleobases [38]. In addition, IlvC, a Ketol-acid reducto-isomerase encoded
by the ilvC gene, is seen to participate during valine, leucine, and isoleucine biosynthesis. Glyoxalases
are principally involved in the conversion of glyoxal to glycolate, therefore facilitating the conversion
of toxins o a non-hazardous product [39]. E. coli poss sses four glyoxalases which belong to the
DJ-1 superfamily, i.e., HchA, YajL, YhbO, and ElbB, the latter present in our analysis. On the other
hand, MgtA, a magnesium-transporting adenosine triphosphatase (ATPase), has a crucial function
in transmembrane transport of electrons or protons. Phosphate acetyltransferase encoded by the pta
gene is the first enzyme of the acetate pathway in the aerobic metabolism. The enzyme catalyzes the
interconversion of acetyl-phosphate and acetyl coenzyme A. Finally, the only protein overexpressed in
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the Tn263 mutant was an aldehyde-alcohol dehydrogenase, encoded by the adhE gene (p = 0.0025).
Under anaerobic conditions, AdhE catalyzes the reduction of acetyl-CoA to acetaldehyde, leading to
an increase of NAD+.
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(a) wt train; (b) Tn263. The arrows mark significa t differences (ANOVA p < 0.05) among the
strains detected by Progenesis SameSpots 4.6.206. Further information about each spot identified can
be found in the supporting information (Supplementary Table S5).
Regarding the proteins identified within the genetic information processing group, we identified
the elongation factor thermostable (EF-ts) which is associated with the elongation factor
Thermo-u stable (EF-Tu) and regulates th exchange of Guanosine 5’-Diphosphate (GDP) to GTP via
aminoacyl-tRNA. The union f EF-ts to ternary structures (EF-Tu-GTP-aa-tRNA) c uld increase the
maximum rate of translation [40]. The cell division protein FtsZ regulated by GTP hydrolysis was
also detected. This protein marks the site where the Z-ring structure divides the cell. Z-ring mutation
could alter the structure and lead to both the development of functional and non-functional cells [41].
Included in the list there was also the DnaK chaperone, the dominant bacterial heat shock protein
(Hsp 70). This is involved in protein secretion and chromosomal DNA replication and interacts with
σ32 for controlling heat shock response. The last protein was the 60 kDa chaperonin GroL. The GroL
chaperonin, also stimulated by σ32, mediates the assembly of unfolded polypeptides generated under
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stress conditions, and together with its regulator GroES, it is necessary for the proper folding of
specific proteins.
Last, within the signalling and cellular process, we found the LptD (lipopolysaccharide transport)
protein which, in combination with LptE protein, has an essential role in the production of
lipopolysaccharide (LPS), the predominant component at the surface of the outer membrane (OM)
of all Gram-negative bacteria. We also found the phosphoenolpyruvate-protein phosphotransferase
enzyme 1 (PtsI) which participates in the phosphotransferase system related to phosphorylation of
carbohydrates in E. coli. Finally, outer membrane protein A (OmpA) was identified as an abundant
protein in E. coli, and it plays a significant role in maintaining cell integrity [42].
3.4.2. Verification of Biofilm-Related Genes by q-RT-PCR
The protein coding-genes corresponding to the proteins previously identified by SDS-PAGE and
mass spectrometry were analysed to investigate possible translational alterations in the mutant sample.
Further validation of these interesting targets was conducted by qRT-PCR between Tn263, the wt strain
and the three biofilm-formers and three non-biofilm-formers clinical isolates.
mRNA detection by qRT-PCR and the subsequent analysis by 2−∆∆Ct method showed that three
genes were downregulated (dnaK, groL, and adhE) and six genes were overexpressed (lptD, cysJ, pta,
ilvC, elbB and ptsI) in the Tn263 mutant compared to the wt strain. Four genes did not present changes
among groups (tsf, ftsZ, ompA, and purL) (Figure 8a). To investigate whether these expression changes
were related to the decreased biofilm formation capacity of the mutant, we assessed the expression
levels of these genes in a collection of well-characterized E. coli clinical isolates. Two genes, adhE
and ptsI presented a significant upregulation in the non-biofilm producers compared to the biofilm
producer strains (p = 0.0347 and p = 0.0169, respectively) (Figure 8b). In the first case, the Tn263 mutant
showed upregulation of the AdhE protein, while it showed a low mRNA expression. However, mRNA
expression in non-biofilm-formers remained upregulated. In the last case, the production of the PtsI
protein was detected as being upregulated in the wt strain, whereas mRNA transcriptional levels were
upregulated in both, the Tn263 and non-biofilm-formers.
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Figure 8. Analysis of the expression of sel cted genes i t t and Tn263 mutants and in clinical
isolates. (a) Heatmap showing the expression levels of biofil -related genes in the wt and Tn263
mutant strains. Expression is presented as a logarithm of their 2−∆∆Ct. Each square shows a biological
replicate (n = 3 vs 3). (b) Scatter plot showing the expression of selected genes in biofilm producer
and non-biofilm producer clinical isolates. Expression is normalised relative to the average expression
of the biofilm producer isolates per each gene (n = X vs X). Each clinical isolate was performed in
triplicate. T test: * p< 0.05, ** p < 0.01, *** p < 0.001.
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4. Discussion
Bacteria have largely been investigated as planktonic cells. However, in many cases, bacteria
grow in communities known as biofilms. These structures offer evolutionary advantages over
their competitors and enable them to overcome environmental stresses. It is therefore important to
understand the factors involved in the development of microbial biofilms that give them phenotypes
different from their planktonic counterparts.
“Omics” techniques, such as high-throughput DNA sequencing, transcriptomic approaches,
or proteomics, can clarify the underlying mechanisms of biofilm production. Progress in this field has
indeed led to numerous studies that provide insight into molecular approaches [43].
The present study aimed to determine new genes involved in biofilm formation in E. coli using
phenotypic and molecular tools comparing E. coli wt strain and the isogenic defective-biofilm mutants
(Tn) generated by transposon insertion. Although the characterisation of the mutants with increased
biofilm production was not within the scope of the present study, this could also lead to interesting
results and warrants further investigations.
In the transposon mutant library, we found deficient mutants in biofilm formation. Two of these
with the most significant loss of biofilm formation capacity were selected for the following analyses.
Tn463 was initially selected as a non-biofilm-forming mutant in the first phenotypic assays.
However, it was later discarded because it had altered fitness and expression in curli fimbriae compared
to the wt strain. Besides, the transposon was inserted into the csgA gene, a previously described gene
that is involved in biofilm formation.
The second one, Tn263 mutant, differed from the wt in its proteomic and transcriptional profiles.
DNA sequencing revealed a transposon insertion in the purL gene, which is involved in the de
novo purine biosynthesis pathway. This pathway plays a critical role in the synthesis of DNA
and RNA. In E. coli, the structural gene pur has various loci either individually (purT, purL, purC,
purA) or collectively within operons (purF, purHD, purMN, purEK) [44]. Concretely, purL gene codes
for formyl-glycinamide ribonucleotide amido-transferase (FGAR-AT), which is an enzyme that
catalyses the fourth step of the purine biosynthetic pathway. This is an ATP-dependent conversion
of formyl-glycinamide ribonucleotide (FGAR) and glutamine to yield N-formylglycinamidine
ribonucleotide (FGAM), adenosine diphosphate (ADP), Pi, and glutamate. In our mutant, the transposon
was located in the N-terminal domain of the purL gene. Previous studies related three principal domains
in purL: the glutaminase, the FGAM synthetase, and the N-terminal domains [45]. The glutaminase
domain produces ammonia, which is transported to the FGAM synthetase domain. The N-terminal
domain possesses an essential function for ammonia channel formation and posterior union between the
two catalytic domains [46]. Changes in the N-terminal domain could potentially alter the interactions
between other structures and block their function without transcriptional modification.
In order to determine whether the purL mutation could cause a fitness deficiency that would
impede the biofilm formation, the mutant strain was grown in LB, without changing its growth rates,
which suggests that the purL mutation does not affect its fitness in this growth medium. However,
fitness was altered in M63 due to the alteration in the purine biosynthetic pathway. Biofilm formation
was carried out in M63 medium at 30 ◦C to favour the expression of genes involved in the biofilm
formation [20,21,47–50] as curli fimbriae, aggregated amyloid structures which promote cell aggregation
and attachment to abiotic surfaces. They are promoted at a temperature less than 32 ◦C inducing
transcription of the csgDEFG operon [51]. Nonetheless, Tn263 and ∆purL::cat mutants showed poor
biofilm formation in the M63 medium compared to the wt strain. On the other hand, when we used the
M63 broth supplemented with inosine in different concentrations, both mutants, Tn263 and ∆purL::cat,
regained the ability to form biofilm. Since both strains can form biofilm in the inosine-supplemented
M63 medium, the lack of biofilm formation could be attributed to the purL disruption. The result was
confirmed by the complementation of the knockout strain. Thus the lack of purines tends to reduce
RNA synthesis by RNA polymerase or amino acid starvation resulting in a deficient biofilm phenotype.
Nhu et al. found that the de novo purine biosynthesis is a critical pathway in curli production [36].
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They hypothesise that a disruption in this pathway reduces the cyclic-di-GMP concentration inside the
cell triggering the transcription of the master regulator csgD. The authors found that purF, purD, purM
and purK mutants were unable to bind CR on YESCA-CR agar. In the same line, Garavaglia et al. also
found that the mutation of the purine biosynthetic gene purH resulted in the inability to produce curli
fibers [52].
Our results support these previous findings because the ∆purL::cat mutant exhibits a curli-deficient
phenotype, resulting in decreased biofilm. However, after supplementation of the growth medium with
inosine, both mutants, Tn263 and ∆purL::cat, restored curli assembly suggesting that purL alteration
and subsequent dysfunction in the purine pathway hinder the efficient transcription of the csgDEFG
operon and csgD expression [52].
Biofilms are an important virulence factor involved in surface colonisation and subsequent
infection, often causing chronic infections. A change in the purine synthesis pathway could reduce
the colonisation rate and thus decrease biofilm infection. For example, disruption in the cvpA-purF or
only the purF genes related to the de novo purine biosynthesis reduces uropathogenic E. coli (UPEC)
internalization into bladder epithelial cells without alteration in epithelium colonisation [53]. Along the
same lines, one study demonstrated that Burkholderia, defected in purl was unable to establish symbiotic
accommodation in Riptortus sp. Burkholderia did not colonize Riptortus sp, even though the bacteria
were capable of colonizing the host midgut. These results suggested that purine biosynthesis also
could play an essential role in infection.
After finding that transposon was inserted into the purL gene, additional studies were conducted
on the changes that this insertion caused at proteomic and transcriptional levels between wt and Tn263.
Comparative proteome analysis revealed 13 proteins statistically significant among wt and Tn263
(Figure 7). Among these proteins, five were found to be closely associated with biofilm regulation.
The two chaperones, DnaK and GroL, are involved in stress response that usually results in the passage
from individual cells to biofilm, inducing the loss of the flagella and performing maintenance activity in
mature biofilm. Specifically, DnaK was involved in the transcriptional regulation of flhDC, responsible
for the flagellum biogenesis, an important organelle associated with biofilm formation, adhesion,
and colonisation [54]. Moreover, a recent work by Sugimoto et al. [55] showed that the DnaK protein
contributes to curli formation. Via rpoS, DnaK modulates the expression of the csgDEF operon which
encodes for CsgD (master transcriptional regulator of curli) acting as a positive regulator of the csgBAC
operon. This last operon encodes the CsgA and CsgB units, the major and minor structural components,
respectively. On the other hand, studies in Cutibacterium acnes hypothesized that the GroL protein
might contribute to the organisation of the biofilm matrix given its ability to bind to external DNA [56].
For this reason, the detection of proteins involved in maintaining a mature biofilm maintenance in the
wt strain supports the idea that the Tn263 mutant was unable to form a biofilm.
Pta enzyme could be indirectly modulate the biofilm formation through acetate intermediates
that can activate regulatory cascades of biofilm formation [57]. For example, acetylation produced by
acetyl-coA from CpxA and UvrY, both members of the two-component regulatory system or RcsB,
are involved in numerous regulatory DNA regions such as colanic acid synthesis, which enhances the
3D structure of the biofilm [58–60].
Another protein involved in biofilm formation that was detected in wt strains was PtsI. In this
case, previous studies on Bacillus cereus showed that mutations in the ptsI gene cause a 70% decrease
in biofilm rates [61]. In avian pathogenic E. coli (APEC), ptsI deletion resulted in motility and
biofilm-deficient bacteria, among other pathogenesis and phenotypic changes [62]. Furthermore,
in E. coli, the internalisation of AI-2, a QS regulator, via Lsr activation, is mediated through ptsI
phosphorylation [63]. Our results reinforce the hypothesis that PtsI is synthesized when bacteria
develop the biofilm, given that PtsI is used to internalise AI-2 in the matrix. The fact that the mutant
strain synthesises a lower amount of PtsI indicates that it is not in confluence and, therefore, it does
not need to synthesize the protein. The last protein detected at high rates and associated with biofilm
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regulation in wt strain was OmpA. Indeed, the study by González Barrios et al. showed that the
presence of an isogenic OmpA mutant decreases biofilm formation [64].
Finally, the only protein with high rates in Tn263 was AdhE. We hypothesise that the mutation
in the purL gene leads to a hypoxic state, therefore activating anaerobic respiration. This idea is
reinforced by studies carried out by Leonardo et al. who showed that using glucose as a carbon source
in anaerobic conditions decreases NADH/NAD+ ratio and changes the expression of the adhE gene [65].
Hence, the adhE gene would be regulated at the transcriptional level by the NADH/NAD+ ratio.
Colón-González et al. also explained that anaerobic growth does not support biofilm formation in
Escherichia coli K-12 by the enzymatic activity of the AdhE protein. adhE gene is induced during oxygen
deficiency, and the authors found significant differences of growth in Congo red agar, where aerobically
grown cells were red (curli +) and anaerobically grown cells were white (curli −) [66]. This suggests a
possible interaction between AdhE expression and defective curli fibers under anaerobic conditions.
AdhE was found to be upregulated in Tn263 compared to the wt strain and does not produce curli
fibers or biofilm. However, this gene is not upregulated among non-biofilm forming clinical strains.
Therefore, we hypothesise that the expression of AdhE in this mutant could be strain-dependent
because it has the purL gene affected by the effect of transposon insertion, whereas the purL gene is not
affected in the wt or the clinical strains.
In summary, we have found a downregulation of Tn263 in the above mentioned proteins (with the
exception of AdhE), all of which are related to the development and maintenance of the biofilm.
Presumably, stress conditions caused by purine deficiency led to DNA damage in Tn263, which reduced
its translational activity.
At the transcriptional level, the corresponding genes of these 13 proteins were analysed revealing
interesting observations. The levels of expression of lptD, pta, elbB, ptsI, cysJ and ilvC genes were higher
in the Tn263 compared to the wt strain. Interestingly, elbB gene was overexpressed significantly in the
Tn263 strain (p < 0.001). This overexpression can be caused by a high level of oxidative stress, which
increases the production of glyoxals [67]. The last gene related to metabolic pathways, pta, showed
increased transcriptional levels in the mutant strain, suggesting that it could use anaerobic metabolic
pathways to synthesize ATP. Transcriptional changes related to the genetic information processing
group showed lower levels of dnaK (p < 0.05) and groL (p < 0.01) in the Tn263 compared to the wt
strain. These data are consistent with previous observations that show the induction of expression
of some genes in the E. coli biofilm, such as dnaK [18]. The ptsI gene expression is reduced in the wt
strain. As PtsI serves as a gateway for phosphoenolpyruvate (PEP), it is likely that the transcription of
PtsI might be reduced once PEP is transported through PtsI. In contrast, the slower metabolism of the
mutant strain may still contain PEP that could be transported by PtsI, whose mRNA remains active.
The adhE gene had lower expression in the Tn263 mutant than in the wt strain. The transcription of
this gene is induced under anaerobic conditions and regulated at the transcriptional and translational
levels by NADH/NAD+ and RNase III, respectively. For this reason, the mRNA transcripts remain at
low rates in Tn263 by this regulation at transcriptional and translational levels [65,68]
Finally, to detect whether these transcriptional changes were related to a biofilm-deficient
phenotype, the genes with statistical significance were tested on biofilm-forming and non-biofilm-
forming clinical strains. The results show disparity with those found in wt and Tn263. All genes
reported equal expression in either group of clinical isolates. Among these nine genes, only two were
significant (adhE and pta) and pta was the only one that followed the same pattern for both Tn263 and
the non-biofilm-forming strains. This may be due to the insertion of the transposon in purL rather than
being associated with a specific biofilm-forming or non-biofilm forming phenotype.
In conclusion, a mutation in the purL gene causes defective biofilm formation, which is related
to the inability to form curli fibers, thus suggesting that this gene is essential for biofilm formation
in E. coli. The proteomic study revealed pathways that belong to expressed biofilm factors, although
the E. coli mutant was not able to form a biofilm. Given this reduction in biofilm formation and the
influence of the biofilm on chronic infections, the identification of the purL gene as a target gene would
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contribute to understanding of the mechanisms of biofilm production and to develop new antibiofilm
treatments against biofilm-related infections caused by this microorganism.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-0817/9/9/774/s1,
Table S1: Biofilm classification of mutants. Low biofilm former (LF), high biofilm former (HF), biofilm former (F),
Table S2: Primers used in the disruption and complementation of the purL gene, Table S3: Antibiotic resistance
profiles of biofilm-forming and non-biofilm-forming clinical isolates, Table S4: qPCR primers used in this study,
Table S5: Protein identification analysed by liquid chromatography coupled to mass spectrometry, Figure S1:
Swimming assay. Figure S2: Two dimensional SDS-PAGE images of the wild type strain, Figure S3: Two
dimensional SDS-PAGE images of the Tn263 mutant.
Author Contributions: Conceptualization, S.M.S., V.C., and Y.L.; methodology, V.C., V.B., M.R., Y.G., and Y.L.;
statistical analysis, V.C. and V.B.; data curation, V.C. and V.B.; writing—original draft preparation, V.C., V.B.,
and S.M.S.; writing—review and editing, V.C., V.B., Y.L., and S.M.S. All authors have read and agreed to the
published version of the manuscript.
Funding: This work was funded by the European Commission under the H2020 program, NoMorFilm Project
(Grant Agreement 634588). ISGlobal is a CERCA center from the Generalitat of Catalunya and a Severo Ochoa
Center (Spanish Ministry of Science, Innovations, and Universities) supported by Planes Nacionales de I+D+i
2008-2011/2013-2016 and Instituto de Salud Carlos III (PI19/00478), Subdirección General de Redes y Centros de
Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious
Diseases (REIPI RD12/0015/0013 and REIPI RD16/0016/0010) co-financed by European Development Regional
Fund “A way to achieve Europe” and operative program Intelligent Growth 2014–2020. Victoria Ballén has a
grant from COLCIENCIAS (Colombia).
Acknowledgments: We thank Yunuen Avalos for her helpful suggestions on protein and molecular biology protocols.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Blount, Z.D. The unexhausted potential of E. coli. Elife 2015, 4, 1–12. [CrossRef] [PubMed]
2. Bentley, R.; Meganathan, R. Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol. Rev. 1982, 46,
241–280. [CrossRef] [PubMed]
3. Lawrence, J.G.; Roth, J.R. Evolution of coenzyme B12 synthesis among enteric bacteria: Evidence for loss
and reacquisition of a multigene complex. Genetics 1996, 142, 11–24. [PubMed]
4. Eggesbø, M.; Moen, B.; Peddada, S.; Baird, D.; Rugtveit, J.; Midtvedt, T.; Bushel, P.R.; Sekelja, M.; Rudi, K.
Development of gut microbiota in infants not exposed to medical interventions. APMIS 2011, 119, 17–35.
[CrossRef]
5. Pratt, L.A.; Kolter, R. Genetic analysis of Escherichia coli biofilm formation: Roles of flagella, motility,
chemotaxis and type I pili. Mol. Microbiol. 1998, 30, 285–293. [CrossRef]
6. Soto, S.M. Importance of biofilms in urinary tract infections: New therapeutic approaches. Adv. Biol. 2014,
2014, 1–13. [CrossRef]
7. Millán-Rodríguez, F.; Palou, J.; Bujons-Tur, A.; Musquera-Felip, M.; Sevilla-Cecilia, C.; Serrallach-Orejas, M.;
Baez-Angles, C.; Villavicencio-Mavrich, H. Acute bacterial prostatitis: Two different sub-categories according
to a previous manipulation of the lower urinary tract. World J. Urol. 2006, 24, 45–50. [CrossRef]
8. Beloin, C.; Roux, A.; Ghigo, J.-M. Escherichia coli biofilms. Curr. Top. Microbiol. Immunol. 2008, 322, 249–289.
[CrossRef]
9. Wright, K.J.; Seed, P.C.; Hultgren, S.J. Uropathogenic Escherichia coli flagella aid in efficient urinary tract
colonization. Infect. Immun. 2005, 73, 7657–7668. [CrossRef]
10. Donlan, R.M.; Costerton, J.W. Biofilms: Survival mechanisms of clinically relevant microorganisms.
Clin. Microbiol. Rev. 2002, 15, 167–193. [CrossRef]
11. Gbejuade, H.O.; Lovering, A.M.; Webb, J.C. The role of microbial biofilms in prosthetic joint infections.
Acta Orthop. 2015, 86, 147–158. [CrossRef] [PubMed]
12. González, J.F.; Hahn, M.M.; Gunn, J.S. Chronic biofilm-based infections: Skewing of the immune response.
Pathog. Dis. 2018, 76, 1–7. [CrossRef] [PubMed]
13. Høiby, N.; Bjarnsholt, T.; Givskov, M.; Molin, S.; Ciofu, O. Antibiotic resistance of bacterial biofilms. Int. J.
Antimicrob. Agents 2010, 35, 322–332. [CrossRef] [PubMed]
14. Belas, R. Biofilms, flagella, and mechanosensing of surfaces by bacteria. Trends Microbiol. 2014, 22, 517–527.
[CrossRef]
Pathogens 2020, 9, 774 20 of 22
15. Kaplan, J.B. Biofilm dispersal: Mechanisms, clinical implications, and potential therapeutic uses. J. Dent. Res.
2010, 89, 205–218. [CrossRef] [PubMed]
16. Sharma, G.; Sharma, S.; Sharma, P.; Chandola, D.; Dang, S.; Gupta, S.; Gabrani, R. Escherichia coli biofilm:
Development and therapeutic strategies. J. Appl. Microbiol. 2016, 121, 309–319. [CrossRef] [PubMed]
17. Klemm, P.; Schembri, M. Type 1 fimbriae, curli, and antigen 43: Adhesion, colonization, and biofilm formation.
Ecosal Plus 2013, 1, 1–18. [CrossRef] [PubMed]
18. Beloin, C.; Valle, J.; Latour-Lambert, P.; Faure, P.; Kzreminski, M.; Balestrino, D.; Haagensen, J.A.J.; Molin, S.;
Prensier, G.; Arbeille, B.; et al. Global impact of mature biofilm lifestyle on Escherichia coli K-12 gene
expression. Mol. Microbiol. 2004, 51, 659–674. [CrossRef]
19. Mehrotra, A. Bacterial Biofilms. Pediatric Asthmaall. Immunol. 2007, 20, 191–195. [CrossRef]
20. Prigent-Combaret, C.; Prensier, G.; Le Thi, T.T.; Vidal, O.; Lejeune, P.; Dorel, C. Developmental pathway
for biofilm formation in curli-producing Escherichia coli strains: Role of flagella, curli and colanic acid.
Environ. Microbiol. 2000, 2, 450–464. [CrossRef]
21. Cepas, V.; López, Y.; Gabasa, Y.; Martins, C.B.; Ferreira, J.D.; Correia, M.J.; Santos, L.M.A.; Oliveira, F.;
Ramos, V.; Reis, M.; et al. Inhibition of bacterial and fungal biofilm formation by 675 extracts from microalgae
and cyanobacteria. Antibiotics 2019, 8, 77. [CrossRef] [PubMed]
22. Hultgren, S.J.; Schwan, W.R.; Schaeffer, A.J.; Duncan, J.L. Regulation of production of type 1 pili among
urinary tract isolates of Escherichia coli. Infect. Immun. 1986, 54, 613–620. [CrossRef] [PubMed]
23. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. Embnet J. 2011,
17, 10. [CrossRef]
24. Schmieder, R.; Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011,
27, 863–864. [CrossRef]
25. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.;
Pham, S.; Prjibelski, A.D.; et al. SPAdes: A new genome assembly algorithm and its applications to single-cell
sequencing. J. Comput. Biol. 2012, 19, 455–477. [CrossRef]
26. Li, H.; Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics
2009, 25, 1754–1760. [CrossRef]
27. Darling, A.C.E. Mauve: Multiple alignment of conserved genomic sequence with rearrangements. Genome Res.
2004, 14, 1394–1403. [CrossRef] [PubMed]
28. Datsenko, K.A.; Wanner, B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR
products. Proc. Natl. Acad. Sci. USA 2000, 97, 6640–6645. [CrossRef]
29. Görg, A.; Weiss, W.; Dunn, M.J. Current two-dimensional electrophoresis technology for proteomics.
Proteomics 2004, 4, 3665–3685. [CrossRef]
30. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature
1970, 227, 680–685. [CrossRef]
31. Chevallet, M.; Luche, S.; Rabilloud, T. Silver staining of proteins in polyacrylamide gels. Nat. Protoc. 2006, 1,
1852–1858. [CrossRef]
32. Marcelino, I.; Colomé-Calls, N.; Holzmuller, P.; Lisacek, F.; Reynaud, Y.; Canals, F.; Vachiéry, N. Sweet
and sour ehrlichia: Glycoproteomics and phosphoproteomics reveal new players in Ehrlichia ruminantium
physiology and pathogenesis. Front. Microbiol. 2019, 10, 1–18. [CrossRef]
33. CLSI. Performance Standards for Antimicrobial Susceptibility, 29th ed.; CLSI supplement M100; Clinical and
Laboratory Standards Institute: Wayne, PA, USA, 2019.
34. Jandu, N.; Ho, N.K.L.; Donato, K.A.; Karmali, M.A.; Mascarenhas, M.; Duffy, S.P.; Tailor, C.; Sherman, P.M.
Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence
of host epithelia. PLoS ONE 2009, 4, e4889. [CrossRef]
35. Reid, S.D.; Herbelin, C.J.; Bumbaugh, A.C.; Selander, R.K.; Whittam, T.S. Parallel evolution of virulence in
pathogenic Escherichia coli. Nature 2000, 406, 64–67. [CrossRef]
36. Nhu, N.T.K.; Phan, M.D.; Peters, K.M.; Lo, A.W.; Forde, B.M.; Chong, T.M.; Yin, W.F.; Chan, K.G.; Chromek, M.;
Brauner, A.; et al. Discovery of new genes involved in curli production by a uropathogenic Escherichia coli
strain from the highly virulent O45:K1:H7 lineage. MBio 2018, 9, 1–16. [CrossRef]
37. Serra, D.O.; Richter, A.M.; Hengge, R. Cellulose as an architectural element in spatially structured
Escherichia coli biofilms. J. Bacteriol. 2013, 195, 5540–5554. [CrossRef]
Pathogens 2020, 9, 774 21 of 22
38. Kozmin, S.G.; Wang, J.; Schaaper, R.M. Role for CysJ flavin reductase in molybdenum cofactor-dependent
resistance of Escherichia coli to 6-N-Hydroxylaminopurine. J. Bacteriol. 2010, 192, 2026–2033. [CrossRef]
39. Lee, C.; Lee, J.; Lee, J.; Park, C. Characterization of the Escherichia coli YajL, YhbO and ElbB glyoxalases.
FEMS Microbiol. Lett. 2016, 363, fnv239. [CrossRef]
40. Burnett, B.J.; Altman, R.B.; Ferrao, R.; Alejo, J.L.; Kaur, N.; Kanji, J.; Blanchard, S.C. Elongation factor Ts directly
facilitates the formation and disassembly of the Escherichia coli elongation factor Tu·GTP·Aminoacyl-tRNA
ternary complex. J. Biol. Chem. 2013, 288, 13917–13928. [CrossRef]
41. Stricker, J.; Erickson, H.P. In Vivo characterization of Escherichia coli ftsZ mutants: Effects on Z-Ring structure
and function. J. Bacteriol. 2003, 185, 4796–4805. [CrossRef] [PubMed]
42. Sonntag, I.; Schwarz, H.; Hirota, Y.; Henning, U. Cell envelope and shape of Escherichia coli: Multiple mutants
missing the outer membrane lipoprotein and other major outer membrane proteins. J. Bacteriol. 1978, 136,
280–285. [CrossRef]
43. Franklin, M.J.; Chang, C.; Akiyama, T.; Bothner, B. New technologies for studying biofilms. Microbiol. Spectr.
2015, 3, 1–24. [CrossRef]
44. Green, S.M.; Malik, T.; Giles, I.G.; Drabble, W.T. The purB gene of Escherichia coli K-12 is located in an operon.
Microbiology 1996, 142, 3219–3230. [CrossRef]
45. Anand, R.; Hoskins, A.A.; Stubbe, J.; Ealick, S.E. Domain organization of Salmonella typhimurium
formylglycinamide ribonucleotide amidotransferase revealed by X-ray crystallography. Biochemistry 2004,
43, 10328–10342. [CrossRef]
46. Zhang, Y.; Morar, M.; Ealick, S.E. Structural biology of the purine biosynthetic pathway. Cell. Mol. Life Sci.
2008, 65, 3699–3724. [CrossRef]
47. Soto, S.M.; Smithson, A.; Martinez, J.A.; Horcajada, J.P.; Mensa, J.; Vila, J. Biofilm formation in uropathogenic
Escherichia coli strains: Relationship with prostatitis, urovirulence factors and antimicrobial resistance. J. Urol.
2007, 177, 365–368. [CrossRef]
48. O’Toole, G.A.; Kolter, R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm
development. Mol. Microbiol. 1998, 30, 295–304. [CrossRef]
49. Vidal, O.; Longin, R.; Prigent-Combaret, C.; Dorel, C.; Hooreman, M.; Lejeune, P. Isolation of an Escherichia coli
K-12 mutant strain able to form biofilms on inert surfaces: Involvement of a new ompR allele that increases
curli expression. J. Bacteriol. 1998, 180, 2442–2449. [CrossRef]
50. Cepas, V.; López, Y.; Muñoz, E.; Rolo, D.; Ardanuy, C.; Martí, S.; Xercavins, M.; Horcajada, J.P.; Bosch, J.;
Soto, S.M. Relationship between biofilm formation and antimicrobial resistance in gram-negative bacteria.
Microb. Drug Resist. 2019, 25, 72–79. [CrossRef]
51. Gualdi, L.; Tagliabue, L.; Bertagnoli, S.; Ieranò, T.; De Castro, C.; Landini, P. Cellulose modulates biofilm
formation by counteracting curli-mediated colonization of solid surfaces in Escherichia coli. Microbiology 2008,
154, 2017–2024. [CrossRef]
52. Garavaglia, M.; Rossi, E.; Landini, P. The pyrimidine nucleotide biosynthetic pathway modulates production
of biofilm determinants in Escherichia coli. PLoS ONE 2012, 7, e31252. [CrossRef]
53. Shaffer, C.L.; Zhang, E.W.; Dudley, A.G.; Dixon, B.R.E.A.; Guckes, K.R.; Breland, E.J.; Floyd, K.A.; Casella, D.P.;
Algood, H.M.S.; Clayton, D.B.; et al. Purine biosynthesis metabolically constrains intracellular survival of
uropathogenic Escherichia Coli. Infect. Immun. 2017, 85, 1–14. [CrossRef]
54. Prüß, B.M.; Besemann, C.; Denton, A.; Wolfe, A.J. A complex transcription network controls the early stages
of biofilm development by Escherichia Coli. J. Bacteriol. 2006, 188, 3731–3739. [CrossRef]
55. Sugimoto, S.; Arita-Morioka, K.; Terao, A.; Yamanaka, K.; Ogura, T.; Mizunoe, Y. Multitasking of Hsp70
chaperone in the biogenesis of bacterial functional amyloids. Commun. Biol. 2018, 1, 52. [CrossRef]
56. Gannesen, A.V.; Zdorovenko, E.L.; Botchkova, E.A.; Hardouin, J.; Massier, S.; Kopitsyn, D.S.; Gorbachevskii, M.V.;
Kadykova, A.A.; Shashkov, A.S.; Zhurina, M.V.; et al. Composition of the biofilm matrix of Cutibacterium acnes
acneic strain RT5. Front. Microbiol. 2019, 10. [CrossRef] [PubMed]
57. Prüß, B.M.; Verma, K.; Samanta, P.; Sule, P.; Kumar, S.; Wu, J.; Christianson, D.; Horne, S.M.; Stafslien, S.J.;
Wolfe, A.J.; et al. Environmental and genetic factors that contribute to Escherichia coli K-12 biofilm formation.
Arch. Microbiol. 2010, 192, 715–728. [CrossRef] [PubMed]
58. Gervais, F.G.; Phoenix, P.; Drapeau, G.R. The rcsB gene, a positive regulator of colanic acid biosynthesis in
Escherichia coli, is also an activator of ftsZ expression. J. Bacteriol. 1992, 174, 3964–3971. [CrossRef]
Pathogens 2020, 9, 774 22 of 22
59. Limoli, D.H.; Jones, C.J.; Wozniak, D.J. Bacterial extracellular polysaccharides in biofilm formation and
function. Microbiol. Spectr. 2015, 3, 1191–1200. [CrossRef] [PubMed]
60. Ma, Q.; Wood, T.K. Protein acetylation in prokaryotes increases stress resistance. Biochem. Biophys.
Res. Commun. 2011, 410, 846–851. [CrossRef]
61. Xu, Y.-B.; Chen, M.; Zhang, Y.; Wang, M.; Wang, Y.; Huang, Q.; Wang, X.; Wang, G. The phosphotransferase
system gene ptsI in the endophytic bacterium Bacillus cereus is required for biofilm formation, colonization,
and biocontrol against wheat sharp eyespot. FEMS Microbiol. Lett. 2014, 354, 142–152. [CrossRef]
62. Wu, X.; Lv, X.; Lu, J.; Yu, S.; Jin, Y.; Hu, J.; Zuo, J.; Mi, R.; Huang, Y.; Qi, K.; et al. The role of the ptsI gene on
AI-2 internalization and pathogenesis of avian pathogenic Escherichia coli. Microb. Pathog. 2017, 113, 321–329.
[CrossRef] [PubMed]
63. Pereira, C.S.; Santos, A.J.M.; Bejerano-Sagie, M.; Correia, P.B.; Marques, J.C.; Xavier, K.B. Phosphoenolpyruvate
phosphotransferase system regulates detection and processing of the quorum sensing signal autoinducer-2.
Mol. Microbiol. 2012, 84, 93–104. [CrossRef] [PubMed]
64. Barrios, A.F.G.; Zuo, R.; Ren, D.; Wood, T.K. Hha, YbaJ, and OmpA regulate Escherichia coli K12 biofilm
formation and conjugation plasmids abolish motility. Biotechnol. Bioeng. 2006, 93, 188–200. [CrossRef]
[PubMed]
65. Leonardo, M.R.; Dailly, Y.; Clark, D.P. Role of NAD in regulating the adhE gene of Escherichia coli. J. Bacteriol.
1996, 178, 6013–6018. [CrossRef]
66. Colón-González, M.; Méndez-Ortiz, M.M.; Membrillo-Hernández, J. Anaerobic growth does not support
biofilm formation in Escherichia coli K-12. Res. Microbiol. 2004, 155, 514–521. [CrossRef] [PubMed]
67. Thornalley, P.J.; Langborg, A.; Minhas, H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in
the glycation of proteins by glucose. Biochem. J. 1999, 344, 109. [CrossRef] [PubMed]
68. Aristarkhov, A.; Mikulskis, A.; Belasco, J.G.; Lin, E.C.C. Translation of the adhE transcript to produce ethanol
dehydrogenase requires RNase III cleavage in Escherichia coli. J. Bacteriol. 1996, 178, 4327–4332. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
